CEN/TC 140
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 68066 | EN ISO 23118:2021 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes in metabolomics in urine, venous blood serum and plasma (ISO/DIS 23118:2020) | Izstrādē |
| 60919 | prEN ISO 23640 rev | In vitro diagnostic medical devices - Evaluation of stability of in vitro diagnostic reagents | Izstrādē |
| 74322 | CEN ISO/TS 5798:2022 | In vitro diagnostic test systems - Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods (ISO/TS 5798:2022) | Izstrādē |
| 61690 | EN ISO 20166-2:2018 | Molecular in vitro diagnostic examinations - Specifications for pre-examinations processes for formalin-fixed and paraffin-embedded (FFPE) tissue - Part 2: Isolated proteins (ISO/DIS 20166-2:2016) | Izstrādē |
| 64589 | - | Molecular in vitro diagnostic examinations - Specifications for preexamination processes for saliva - Isolated DNA | Izstrādē |
| 5089 | - | Methods for the determination of performance of culture media | Izstrādē |
| 29669 | LVS EN ISO 15189:2013 A | Medical laboratories - Requirements for quality and competence (ISO 15189:2012, Corrected version 2014-08-15) | Atcelts |
| 65450 | CEN/TS 17390-1:2020 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for circulating tumor cells (CTCs) in venous whole blood - Part 1: Isolated RNA | Atcelts |
| 27617 | EN ISO 18113-2:2009 | In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 2: In vitro diagnostic reagents for professional use (ISO/FDIS 18113-2:2009) | Atcelts |
| 24023 | LVS EN ISO 15197:2003 /AC:2005 | In vitro diagnostic test systems - Requirements for blood- glucose monitoring systems for self-testing in managing diabetes mellitus | Atcelts |
Displaying 61-70 of 282 results.